Benlysta

Discussion in 'GlaxoSmithKline' started by anonymous, Sep 23, 2016 at 7:44 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I am interested in a position posted selling Benlysta. I currently call on Rhem, and would like to learn more about this position that is open. Any thoughts on the product, position, if this is a good move?
     

  2. anonymous

    anonymous Guest

    Simple answer is NO. Crap product that has marginal benefit. Believe it or not but a Moroccan R&D exec convinced a dimwitted CEO that this was a great purchase for $3 billion. That's one of many reasons why both are being forced into retirement
     
  3. anonymous

    anonymous Guest

    Sage advice.